Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fisher

Showing results (51-60 of 146) with videos related to

Pageof 15
Sort By:
Pharmaceutical Research|July 24, 2002
Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actionsAnna Astriab-Fisher, Dimitri Sergueev, Michael Fisher, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2020
Children drinking private well water have higher blood lead than those with city waterJacqueline MacDonald Gibson, Michael Fisher, Allison Clonch, et al.
Nucleic Acids Research|June 17, 2010
Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptorXin Ming, Md Rowshon Alam, Michael Fisher, et al.
Nucleic Acids Research|February 1, 2007
Inhibition of MDR1 expression with altritol-modified siRNAsMichael Fisher, Mikhail Abramov, Arthur Van Aerschot, et al.
Toxicology|August 9, 2002
Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced gene expression profile in vivo using pathway-specific cDNA arraysAhmet Zeytun, Robert J McKallip, Michael Fisher, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 20, 2002
Regulation of interleukin-2-induced vascular leak syndrome by targeting CD44 using hyaluronic acid and anti-CD44 antibodiesAmjad Mustafa, Robert J McKallip, Michael Fisher, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Delivery of MDR1 small interfering RNA by self-complementary recombinant adeno-associated virus vectorDong Xu, Doug McCarty, Alda Fernandes, et al.
Journal of Biomedical Nanotechnology|January 9, 2010
Size-uniform 200 nm particles: fabrication and application to magnetofectionLamar Mair, Kris Ford, M d Rowshon Alam, et al.
Oligonucleotides|December 30, 2009
The biological effect of an antisense oligonucleotide depends on its route of endocytosis and traffickingMd Rowshon Alam, Xin Ming, Vidula Dixit, et al.
Infection and Immunity|December 25, 2004
Role of CD44 and its v7 isoform in staphylococcal enterotoxin B-induced toxic shock: CD44 deficiency on hepatic mononuclear cells leads to reduced activation-induced apoptosis that results in increased liver damageRobert J McKallip, Michael Fisher, Ursula Gunthert, et al.
Pageof 15

Showing results (51-60 of 146) with videos related to

Sort By:
Pageof 15
Pharmaceutical Research|July 24, 2002
Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actionsAnna Astriab-Fisher, Dimitri Sergueev, Michael Fisher, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2020
Children drinking private well water have higher blood lead than those with city waterJacqueline MacDonald Gibson, Michael Fisher, Allison Clonch, et al.
Nucleic Acids Research|June 17, 2010
Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptorXin Ming, Md Rowshon Alam, Michael Fisher, et al.
Nucleic Acids Research|February 1, 2007
Inhibition of MDR1 expression with altritol-modified siRNAsMichael Fisher, Mikhail Abramov, Arthur Van Aerschot, et al.
Toxicology|August 9, 2002
Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced gene expression profile in vivo using pathway-specific cDNA arraysAhmet Zeytun, Robert J McKallip, Michael Fisher, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 20, 2002
Regulation of interleukin-2-induced vascular leak syndrome by targeting CD44 using hyaluronic acid and anti-CD44 antibodiesAmjad Mustafa, Robert J McKallip, Michael Fisher, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Delivery of MDR1 small interfering RNA by self-complementary recombinant adeno-associated virus vectorDong Xu, Doug McCarty, Alda Fernandes, et al.
Journal of Biomedical Nanotechnology|January 9, 2010
Size-uniform 200 nm particles: fabrication and application to magnetofectionLamar Mair, Kris Ford, M d Rowshon Alam, et al.
Oligonucleotides|December 30, 2009
The biological effect of an antisense oligonucleotide depends on its route of endocytosis and traffickingMd Rowshon Alam, Xin Ming, Vidula Dixit, et al.
Infection and Immunity|December 25, 2004
Role of CD44 and its v7 isoform in staphylococcal enterotoxin B-induced toxic shock: CD44 deficiency on hepatic mononuclear cells leads to reduced activation-induced apoptosis that results in increased liver damageRobert J McKallip, Michael Fisher, Ursula Gunthert, et al.
Pageof 15